Project Number 5U54NS123746-02 Agency/Funding Organization NINDS Funding Year 2022 View Full Project Details for Project 2: Impact of H1/H2 haplotypes on cellular disease-associated phenotypes driven by FTD-causing MAPT mutations Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 2. Tau c. Tau-Mediated Pathogenesis (AD and ADRD) Researcher and Organization Principal Investigator GESCHWIND, DANIEL H Principal Investigator First Name DANIEL H Principal Investigator Last Name GESCHWIND Awardee Organization ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-NS-21-003: Center without Walls for Molecular Mechanisms of Neurodegeneration in Frontotemporal Degeneration (FTD) (U54 Clinical Trial not Allowed) FY Overall Cost $561,827 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official MCGAVERN, LINDA
